Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Research undertaken by Amel Dudakovic, Ph.D., is focused on advancing the health of patients affected by musculoskeletal conditions. Specifically, his studies aim to identify molecular events that can be targeted to address bone, cartilage and fibrotic conditions. To achieve this goal, Dr. Dudakovic uses his background in molecular and cell biology to understand the basis of human disease and then applies his pharmacology training to identify suitable cell-based and pharmacological strategies to prevent and combat these musculoskeletal ailments.
Musculoskeletal diseases have significant health and economic impacts. The burden of treating musculoskeletal disease is expected to increase in the future as populations age. Dr. Dudakovic's studies aim to gain insight into and define the mechanisms that contribute to musculoskeletal tissue formation and degeneration. An enhanced understanding of these processes may decrease the impact of musculoskeletal diseases by helping researchers design strategies that can prevent and restore damaged tissues.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.